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Context: The effect of weight loss by diet alone or diet in conjunction with exercise on
low-grade inﬂammation in non-obese (overweight) individuals is not known. Objective:
Test the hypothesis that 24 weeks of moderate calorie restriction (CR; 25%) by diet only
or with aerobic exercise would reduce markers of systemic inﬂammation and attenuate
inﬂammation gene expression in subcutaneous adipose tissue. Design: Randomized con-
trolled trial. Setting: Institutional Research Center. Participants: Thirty-ﬁve overweight
(body mass index: 27.8 ± 0.7 kg/m2) but otherwise healthy participants (16M/19F) com-
pleted the study. Intervention: Participants were randomized to either CR (25% reduction
in energy intake, n = 12), caloric restriction + exercise (CR + EX: 12.5% reduction in
energy intake + 12.5% increase in exercise energy expenditure, n = 12), or control
(healthy weight-maintenance diet, n = 11) for 6 months. Main outcome measures: Fast-
ing serum markers of inﬂammation [leptin, highly sensitive C-reactive protein (hsCRP),
interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), adiponectin] and inﬂammation-
related genes [CD68, IL-6, TNF-α, macrophage migration inhibitory factor (MIF), monocyte
chemoattractant protein-1 (MCP-1), adiponectin, plasminogen activator inhibitor-1 (PAI-
1)] in subcutaneous adipose tissue. Results: CR and CR + EX lost similar amounts of
body weight (−10 ± 1%), fat mass (−24 ± 3%), visceral fat (−27 ± 3%), and had
increased insulin sensitivity (CR: 40 ± 20%, CR + EX: 66 ± 22%). Leptin was sig-
niﬁcantly decreased from baseline (p < 0.001) in both groups however TNF-α and IL-6
were not changed. hsCRP was decreased in CR + EX. There was no change in the
expression of genes involved in macrophage inﬁltration (CD68, MIF, MCP-1, PAI-1) or
inﬂammation (IL-6, TNF-α, adiponectin) in either CR or CR + EX. Conclusion: A 10%
weight loss with a 25% CR diet alone or with exercise did not impact markers of sys-
temic inﬂammation or the expression of inﬂammation-related adipose genes in overweight
individuals.
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INTRODUCTION
Chronic low-grade systemic inﬂammation is a hallmark of obe-
sity (Gregor and Hotamisligil, 2011). As adipose tissue expands,
it is characterized by enlarged adipocytes and macrophage
accumulation, resulting in increased circulating leptin, pro-
inﬂammatory cytokines [interleukin-6 (IL-6), tumor necrosis
factor-alpha (TNF-α)] and chemokines [monocyte chemoattrac-
tant protein-1 (MCP-1)], and lower adiponectin levels (Rud-
man et al., 1990). These factors, indicative of chronic sys-
temic low-grade inﬂammation, are believed to be involved in
the pathogenesis of cardiovascular disease (Pai et al., 2004),
insulin resistance and type 2 diabetes (Festa et al., 2000). Poten-
tial mechanisms linking obesity-associated low-grade inﬂamma-
tion and metabolic dysfunction include activation of cytokine
or toll-like receptor signaling pathways which can access cel-
lular targets directly or via chaperoning molecules. Conse-
quently, three prominent kinases, JNK, IKK, and PKR, down-
stream of these signaling pathways have important roles in
relaying stress signals throughout the cell (Gregor and Hotamis-
ligil, 2011).
Interventions which reduce adipose tissue mass such as low-
calorie diet (LCD; Esposito et al., 2003; Clement et al., 2004)
or bariatric surgery (Cancello et al., 2005) generally result in
decreased systemic and local adipose tissue inﬂammation. How-
ever, the majority of these investigations have been performed
in obese individuals (Esposito et al., 2003; Clement et al., 2004;
Cancello et al., 2005; Dahlman et al., 2005; Viguerie et al., 2005;
Franck et al., 2011). Given that overweight subjects have a strong
tendency to transition to obesity, identifying whether inﬂam-
mation perturbations occur during the overweight period may
be clinically relevant and is currently not known (Singh et al.,
2008; Herman et al., 2009). In addition, calorie restriction (CR),
a dietary intervention that delivers reduced calories while main-
taining proper nutrition has potent anti-inﬂammatory effects in
primates (Kim et al., 1997) and in humans self-prescribing CR
diets (Fontana et al., 2004). The anti-inﬂammatory effects of CR
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could be mediated by one or more of the following CR-induced
changes; reduced adiposity and secretion of pro-inﬂammatory
mediators, reduced oxidative stress, and increased insulin
sensitivity.
The Pennington CALERIE study was a 24-week study in
young, overweight adults testing the hypothesis that CR improves
biomarkers of longevity (Heilbronn et al., 2006). We have pre-
viously found that fasting insulin and core body temperature
were reduced with CR while dehydroepiandrosterone sulfate
(DHEA-S)wasunchanged (Heilbronn et al., 2006). An exploratory
endpoint of the study was to test the hypothesis that 24 weeks
of moderate CR (25%) would reduce markers of systemic
inﬂammation and attenuate expression of pro-inﬂammatory
genes in subcutaneous adipose tissue. We hypothesized that
overweight individuals would have increased systemic and adi-
pose tissue inﬂammation gene expression, which would be
reduced by a 25% energy deﬁcit by diet and/or aerobic
exercise.
MATERIALS AND METHODS
ETHICS STATEMENT
This study was conducted according to the principles expressed
in the declaration of Helsinki. The study was approved by the
Pennington Biomedical Research Center IRB and the Data Safety
Monitoring Board of CALERIE. All participants provided written
informed consent for the collection of samples and subsequent
analysis.
PARTICIPANTS
Of the 599 individuals screened for the study, 551 were excluded
(460 were ineligible; 91 withdrew during screening; Figure 1).
Thirty-ﬁve overweight [25 ≤ body mass index (BMI) < 30] but
otherwise healthy men (25 to <50 years) and pre-menopausal
women (25 to <45 years) from the Pennington CALERIE study
are included in this analysis (Heilbronn et al., 2006). Subject eligi-
bilitywas assessed in three screening visits andwith comprehensive
testing. Participants were excluded if they smoked, exercised
FIGURE 1 | Flow of all participants through the Phase 1 CALERIE trial in Baton Rouge and the subset of subjects with inflammatory assessments.
Note the fourth group (low-calorie group highlighted in gray) was excluded from the inﬂammatory marker analysis.
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more than twice per week, were pregnant, lactating or post-
menopausal, had a personal history of obesity (BMI never greater
than 32 kg/m2), cardiovascular disease, diabetes, or regularly used
medications (except birth control). Details of the screeningprocess
and study population have been extensively described (Heilbronn
et al., 2006). A copy of the full study protocol can be obtained at
www.clinicaltrials.gov
STUDY DESIGN
Following a 5-week baseline period, subjects were random-
ized into one of four groups for 24 weeks: Control = healthy
weight-maintenance diet based on the American Heart Associ-
ation (AHA) Step 1 guidelines. (5M/6F), CR = 25% CR from
baseline energy requirements (6M/6F), caloric restriction + exer-
cise (CR + EX) = 12.5% CR and 12.5% increase in exercise
energy expenditure (5M/7F). The study also included a fourth
group (LCD) however since the goal of this treatment group was
to achieve a speciﬁc weight loss followed by weight maintenance
(and not to sustain a deﬁned level of CR), this group was excluded
from the inﬂammation analyses.
INTERVENTIONS
Individualized energy intakes were prescribed from two consec-
utive measures of energy expenditure by doubly labeled water at
baseline (Larson-Meyer et al., 2010). During 3 weeks at baseline
and weeks 1–12 and 22–24 of the intervention, participants con-
sumed a diet based on the AHA guidelines, 30% calories from fat,
15% from protein, and 55% from carbohydrate. The diets were
prepared by the Metabolic Kitchen at the Pennington Biomedi-
cal Research Center. For weeks 13–22 participants followed their
assigned dietary prescription by self-selection. Dietary intake and
bodyweight weremonitoredweekly to ensure compliance. CR and
Control participants were required to continue their usual pat-
tern of physical activity throughout the study while participants
in CR + EX increased their energy expenditure by 12.5% above
baseline through structured supervised aerobic exercise sessions,
5 days/week according to an individualized exercise prescription
(Larson-Meyer et al., 2010).
CLINICAL ASSESSMENTS
Body composition by dual x-ray absorptiometry (Hologics QDR
4500A, Bedford, MA, USA), abdominal fat distribution by multi-
slice computed tomography (GE Light Speed, General Electric,
Milwaukee, WI, USA) and fasting blood and adipose tissue biop-
sies were collected during a 5-day inpatient stay at baseline and
24weeks after the intervention (Larson-Meyer et al., 2010). Insulin
sensitivity (Si) and acute insulin response to glucose (AIRg) were
determined by the modiﬁed frequently sampled intravenous glu-
cose tolerance test (Heilbronn et al., 2006) at baseline and 24weeks
after the intervention. All clinical investigators conducting clinical
assessments with the exception of the study physicianwere blinded
to the treatment assignment.
BIOCHEMICAL ASSAYS
Highly sensitive C-reactive protein (hsCRP) was determined
by chemiluminescent immunoassay (Immulite 2000TM, Siemens
Healthcare Diagnostics, Deerﬁeld, IL, USA); TNF-α and IL-6
by immunoassay (Luminex 100TM, Luminex Corp., Austin, TX,
USA); and leptin and adiponectin concentrations by radioim-
munoassay (Linco Research Inc., St Charles, MO, USA).
Tissue collection and gene expression analysis
Approximately, 350 mg of subcutaneous adipose tissue was col-
lected from the abdomen (5 cm to left/right of the umbilicus)
using a Bergstrom needle. Repeat biopsies were obtained no less
than 1 cm from the previous biopsy incision site, in compli-
ance with standard clinical practice at our Center. Fat cell size
was determined by the Multisizer-3 counter (Beckman Coulter,
Fullerton, CA, USA) as previously described (Heilbronn et al.,
2004). RNA from ∼100 mg of tissue was isolated by column
puriﬁcation (Qiagen,Valencia, CA,USA) and yield determined by
spectrophotometry (NanoDrop Technologies, Wilmington, DE,
USA). From each RNA sample, 200 ng was reverse transcribed
to cDNA using the High Capacity cDNA Reverse Transcrip-
tion kit (Applied Biosystems, Foster City, CA, USA). Relative
quantiﬁcation of mRNA expression was analyzed using ABI
PRISM 7900 (Applied Biosystems, Branchburg, NJ, USA) and
custom Taqman gene expression micro ﬂuidic cards for TNF-α
(Hs00174128_m1), IL-6 (Hs00985639_m1), macrophage marker
(CD68, Hs00154355_m1), macrophage migration inhibitory
factor (MIF, Hs00236988_g1), MCP-1 (Hs00234140_m1), plas-
minogen activator inhibitor-1 (PAI-1, Hs01126603_m1), and
adiponectin (Hs00605917_m1). Samples were run in tripli-
cate and expression levels were normalized to cyclophilin B
(Hs00168719_m1). CyclophilinBwas not changedby treatment in
either group (CR: p = 0.35, CR + EX: p = 0.62, Control: p = 0.76)
and there was no treatment effect (p = 0.37).
STATISTICAL ANALYSES
Data are presented as means ± SEM. SAS Version 9.12 (SAS Insti-
tute, Cary, NC, USA) was used for analysis. The change and
percent change from baseline to month 6 was calculated for all
variables, and between group differences (CR, CR + EX, Con-
trol) were tested by analysis of covariance with baseline values
included in the model as covariates. Statistical signiﬁcance for
all multiple comparisons was adjusted using Tukey–Kramer to
avoid type I errors. Statistical signiﬁcance was considered when
p < 0.05.
RESULTS
SUBJECT CHARACTERISTICS
At baseline the groups did not differ with respect to demographic
data, body weight, adiposity, or insulin sensitivity (Table 1).
There were no associations between body weight, percent body fat,
abdominal visceral fat mass, subcutaneous fat cell size, or insulin
sensitivity and inﬂammation gene expression.
Effects of CR on body weight, body composition, insulin sensitivity
As previously reported (Heilbronn et al., 2006), 25% energy deﬁcit
by diet alone (CR) or diet plus exercise (CR + EX) resulted
in similar and signiﬁcant reductions in body weight, fat mass,
and abdominal visceral fat (Table 1). There was an improve-
ment in insulin sensitivity however it only reached signiﬁcance in
CR + EX.
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Table 1 | Effect of caloric restriction alone and with exercise on body composition, insulin sensitivity, and systemic markers of inflammation.
Control (5M/6F) CR (6M/6F) CR + EX (5M/7F)
BL % BL % BL %
Demographics
Age (year) 37.7 ± 2.2 − 38.4 ± 1.6 − 35.5 ± 1.6 −
BMI (kg/m2) 27.6 ± 2.0 −1 ± 1 27.8 ± 1.4 −10 ± 1 27.5 ± 1.6 −10 ± 1
Body composition and insulin sensitivity
Weight (kg) 82.3 ± 2.9 −1 ± 1 81.2 ± 3.3 −10 ± 1* 82.1 ± 3.1 −10 ± 1*
FM (kg) 25.5 ± 1.2 −2 ± 3 24.9 ± 1.8 −24 ± 3* 26.4 ± 1.7 −25 ± 3*
VAT (kg) 2.9 ± 0.4 −2 ± 4 3.2 ± 0.5 −28 ± 4* 2.8 ± 0.4 −27 ± 3*
Fat cell size (μl) 0.73 ± 0.05 4 ± 7 0.65 ± 0.05 −20 ± 5* 0.70 ± 0.04 −26 ± 6*
Insulin sensitivity (Si) 2.8 ± 1.2 1 ± 11 3.3 ± 1.7 40 ± 20 3.4 ± 0.4 66 ± 22*
AIRg 750 ± 135 −17 ± 10 815 ± 136 −35 ± 9 729 ± 175 −36 ± 9*
Glucose (mg/dl) 93 ± 2 3.0 ± 1.5 91 ± 3 −0.4 ± 1.3 93 ± 27 7.7 ± 8.5
Insulin (μU/ml) 12 ± 4 0.01 ± 8.4 9 ± 1 −28.8 ± 6.3 10 ± 1 −26.4 ± 12.5
Serum inflammatory markers
Adiponectin (ng/ml) 2997 ± 297 6 ± 4 3253 ± 302 14 ± 3 3440 ± 270 7 ± 4
TNF-α (pg/ml) 8.0 ± 1.4 44 ± 11 8.5 ± 2.0 64 ± 31 7.2 ± 1.7 79 ± 43
IL-6 (pg/ml) 145.9 ± 59.5 9 ± 14 66.5 ± 20.2 44 ± 21 131.5 ± 42.4 5 ± 8
Leptin (ng/ml) 19.3 ± 3.8 −2 ± 8 14.3 ± 3.1 −39 ± 10* 18.3 ± 3.7 −52 ± 8*
CRP (mg/l) 0.30 ± 0.08 −27 ± 8 0.25 ± 0.07 29 ± 53 0.15 ± 0.03 −27 ± 8*
Gene expression (mRNA;AU)
Adiponectin 0.84 ± 0.06 −6 ± 6 0.71 ± 0.04 11 ± 11 0.94 ± 0.09 36 ± 47
IL-6 4.00 ± 0.53 19 ± 25 3.87 ± 0.74 91 ± 31 12.30 ± 5.98 358 ± 349
TNF-α 1.28 ± 0.22 30 ± 25 1.99 ± 0.35 −3 ± 26 1.87 ± 0.27 42 ± 30
CD68 0.63 ± 0.17 10 ± 17 0.99 ± 0.28 −8 ± 22 0.60 ± 0.06 31 ± 33
MIF 0.76 ± 0.08 −2 ± 9 0.74 ± 0.09 −8 ± 11 0.86 ± 0.10 23 ± 38
MCP-1 1.11 ± 0.25 20 ± 14 1.59 ± 0.37 7 ± 9 1.94 ± 0.43 111 ± 126
PAI-1 2.40 ± 0.63 −31 ± 27 1.98 ± 0.81 208 ± 192 2.04 ± 0.50 −22 ± 50
Baseline data (BL) and the change from baseline (expressed as a percent) are reported by treatment group (mean ± SEM). Insulin sensitivity was measured by
frequently sampled glucose tolerance test. This table presents data on serum and mRNA adipose tissue expression of inﬂammatory mediators. Relative quantity of
mRNA was determined from delta-delta CT method, where cyclophilin B was the reference gene. CR, caloric restriction; CR + EX, caloric restriction + exercise;
BMI, body mass index; FM, fat mass; VAT, visceral adipose tissue; TNF-α, tumor necrosis factor-alpha; IL-6, interleukin 6; CRP, c-reactive protein; MCP-1, monocyte
chemoattractant protein-1; MIF, macrophage migration inhibitory factor; PAI-1, plasminogen activator inhibitor-1.
*Denotes change is signiﬁcantly different from baseline, p < 0.05.
Effects of CR on markers of systemic inﬂammation and
expression of inﬂammation-related genes in subcutaneous
adipose tissue
Consistentwith the loss of fatmass, therewas a signiﬁcant decrease
in serum leptin concentrations in CR and CR + EX (Table 1). We
also observed a signiﬁcant increase in IL-6 with CR, however, this
effect was driven by one subject who had a 477% increase in IL-6
concentrations. When this subject was omitted from the analysis,
the effect was no longer signiﬁcant. Serum levels of hsCRP and
TNF-α did not change from baseline in CR however hsCRP was
signiﬁcantly reduced in CR + EX (Table 1).
There was no change in the relative mRNA level for any of the
genes measured: IL-6, TNF-α, CD68, MIF, MCP-1, adiponectin,
PAI-1 with the 24-week intervention (Figure 2). The percent
change in weight, fat mass, visceral fat mass, abdominal adipocyte
size, or insulin sensitivity was not related to the percent change
mRNA expression of any inﬂammatory genes.
Given the lack of difference between CR and CR + EX, we
pooled the two groups and tested the hypothesis that CR/CR+ EX
would decrease inﬂammation versus controls. We did not detect
any differences between CR/CR+ EX and controls in either serum
markers or gene expression (data not shown).
DISCUSSION
In this study, overweight subjects completed a 24-week interven-
tion producing a 25% energy deﬁcit by diet alone (CR) or diet in
conjunction with structured supervised exercise (CR + EX). The
two intervention groups had similar reductions in body weight,
total fat mass, and visceral fat and a wide range of circulating and
gene expression inﬂammation markers were measured pre- and
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FIGURE 2 | Effect of a 25% energy deficit by diet (CR) or diet in conjunction with exercise (CR + EX) on the adipose tissue gene expression of
adipokines. Gene expression shown normalized to cyclophilin B. Black bar: Control group; light gray bar: CR group; dark gray bar: CR + EX group. Data are
mean ± SEM.
post-intervention. Contrary to our hypothesis, CR did not reduce
circulating inﬂammatory markers or inﬂammation gene expres-
sion in subcutaneous adipose tissue. Furthermore CR + EX did
not promote an anti-inﬂammatory response aside from a small,
albeit signiﬁcant lowering of hsCRP.
Several randomized controlled trials have been conducted to
test the impact of weight loss by diet and/ or exercise on low-grade
inﬂammation in obesity (Esposito et al., 2003; Clement et al., 2004;
Christiansen et al., 2005, 2010; Bruun et al., 2006; Klimcakova
et al., 2006; Polak et al., 2006; Capel et al., 2009). The consen-
sus from these studies is that a threshold for weight loss (i.e.,
10%) may be necessary to elicit an improvement in the inﬂam-
matory state (Forsythe et al., 2008). For example, a 12-week study
found that serum markers (MIP-1α, IL-15) were reduced in obese
subjects if weight loss exceeded 14.5% regardless of the type of
intervention (diet or diet with exercise; Christiansen et al., 2010).
However, mRNA expression of pro-inﬂammatory cytokines (IL-6
andTNFα) andmacrophagemarkers (CD68 andMCP-1)were not
altered. In studies with little or no effect of weight loss on inﬂam-
matory outcomes (Klimcakova et al., 2006; Polak et al., 2007), it
may be that the initial level of obesity was not sufﬁcient for
inducing systemic and/or local inﬂammation in subcutaneous
adipose tissue. Certainly, in subjects with obesity and morbid
obesity, weight loss by diet (Esposito et al., 2003; Clement et al.,
2004; Christiansen et al., 2005) and/or exercise (Bruun et al., 2006;
Christiansen et al., 2010) and bariatric surgery (Cancello et al.,
2005) drastically reduces pro-inﬂammatory cytokines in serum
and mRNA expression of adipokines in subcutaneous adipose
tissue. We speculate that the healthy overweight subjects in our
cohort who never had a BMI greater than 32 kg/m2 did not
have obesity-induced low-grade inﬂammation from the outset,
thereby leading to a negative ﬁnding for diet and exercise medi-
ated improvements in inﬂammation. It has been hypothesized that
fasting/feeding cycles induce low-level inﬂammatory responses in
metabolic cells from lean animals, and it is only when chronic
nutrient excess occurs that the inﬂammatory response reaches a
certain threshold and a more harmful inﬂammatory response is
activated (Gregor andHotamisligil, 2011). Indeed, even 8 weeks of
overfeeding (3200–5800 kJ/day) in lean to overweight individuals
resulting in 3–4% weight gain is not sufﬁcient to alter circulat-
ing and local inﬂammation markers (Tam et al., 2010; Alligier
et al., 2011). Furthermore, the baseline CRP levels in this study
were considerably lower than CRP levels described in morbidly
obese subjects (2–6mg/l; Holdstock et al., 2005; Hofso et al., 2009).
Coupled with the ﬁndings in the current study, it may be that a
threshold of weight gain/loss is required for inﬂammation to be
induced, or reversed.
Obesity-induced inﬂammation is especially present when adi-
posity is in the visceral depot (Alvehus et al., 2010) since several
inﬂammatory markers such as PAI-1, MIF, CCL2 are preferen-
tially expressed in visceral fat (Forsythe et al., 2008). Given that
the inﬂammatory state in obesity is not improved by removal of
subcutaneous fat with liposuction (Klein et al., 2004), a reduc-
tion of visceral fat in diet and exercise studies is probably most
important (Chaston and Dixon, 2008). Therefore, measuring the
expression of genes in the visceral fat, albeit impossible in most
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clinical studies,may provide further insights into the effects of diet
and/or exercise on low-grade inﬂammation in overweight individ-
uals. A limitation of our study is the relatively low sample size as
our analysis was an exploratory end point of the parent study. Nev-
ertheless, the sample size of this study was similar to previously
published studies looking at the effects of diet and/or exercise
interventions on inﬂammation (Forsythe et al., 2008).
In summary, our data indicates that evenwith a 10%weight loss
and 30% reduction in visceral fat, there was no marked improve-
ment in systemic or markers of inﬂammation in subcutaneous
adipose tissue probably due to the general good health of our
overweight and not obese participants.
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